Lunai Bioworks Inc.
Data quality: 83%
LNAI
Nasdaq
Manufacturing
Chemicals
$0.40
▲
$0.05
(13.17%)
Mkt Cap: 9.78 M
Price
$0.40
Mkt Cap
9.78 M
Day Range
$0.33 — $0.44
52-Week Range
$0.15 — $5.50
Volume
5,734,199
Open $0.34
50D / 200D Avg
$0.52
22.08% below
50D / 200D Avg
$1.46
72.29% below
Quick Summary
Key Takeaways
Negative free cash flow of -5.79 M
Growth
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
N/A
ROICN/A
Net MarginN/A
Op. MarginN/A
Safety
Debt / Equity
N/A
Current Ratio0.03
Interest Coverage-219.48
Valuation
PE (TTM)
-0.08
Above sector avg (-1.48)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A
Price History
Financial Trends
Peer Comparison
vs Manufacturing sector median (1364 peers)
Peer Comparison
vs Manufacturing sector median (1364 peers)| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -0.1 | -1.5 |
| P/B | — | 1.6 |
| ROE % | — | -53.4 |
| Net Margin % | — | -41.5 |
| Rev Growth 5Y % | — | 1.8 |
| D/E | — | 0.3 |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | N/A | Net Income (TTM) | -125.52 M |
| ROE | N/A | ROA | -1842.26% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -5.79 M |
| ROIC | N/A | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 0.03 |
| Interest Coverage | -219.48 | Asset Turnover | N/A |
| Working Capital | -19.49 M | Tangible Book Value | -19.65 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -0.08 | Forward P/E | N/A |
| P/B Ratio | N/A | P/S Ratio | N/A |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -59.21% | ||
| Market Cap | 9.78 M | Enterprise Value | 9.29 M |
| Per Share | |||
| EPS (Diluted TTM) | -0.72 | Revenue / Share | N/A |
| FCF / Share | -0.24 | OCF / Share | -0.24 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | N/A | FCF Conversion | 4.61% |
| SBC-Adj. FCF | -6.86 M | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Net Income | -178.01 M | -80.65 M | -39.68 M | -113.43 M | -26.72 M |
| EPS (Diluted) | -1.08 | -0.84 | -0.71 | — | — |
| Gross Profit | — | — | — | — | — |
| Operating Income | -188.97 M | -81.64 M | -38.56 M | -116.08 M | -23.40 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | 537,428.0 | 2.71 M | 4.17 M | 8.37 M | 15.54 M |
| SG&A Expenses | — | — | — | — | — |
| D&A | 129,095.0 | 121,859.0 | 113,496.0 | 123,590.0 | 123,535.0 |
| Interest Expense | 725,684.0 | 1.01 M | 580,344.0 | 372,844.0 | 379,608.0 |
| Income Tax | 1,474.0 | — | 34.0 | 34.0 | -125,276.0 |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 8.23 M | 163.13 M | 58.30 M | 84.63 M | 189.61 M |
| Total Liabilities | 29.58 M | 31.15 M | 11.80 M | 12.01 M | — |
| Shareholders' Equity | -21.35 M | 131.98 M | 46.50 M | 72.62 M | 174.66 M |
| Total Debt | — | — | — | — | — |
| Cash & Equivalents | 92,700.0 | 220,467.0 | 1.87 M | 9.17 M | 20.66 M |
| Current Assets | 1.05 M | 2.00 M | 2.57 M | 9.57 M | 20.90 M |
| Current Liabilities | 29.16 M | 30.31 M | 11.02 M | 6.45 M | 1.89 M |
{"event":"ticker_viewed","properties":{"ticker":"LNAI","listing_kind":"stock","pathname":"/stocks/lnai","exchange":"Nasdaq","country":"US"}}